GRI Bio, Inc. , a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States.
Gri Bio stock last closed at $1.12, up 0% from the previous day, and has decreased 98.04% in one year. It has underperformed other stocks in the Biotechnology industry by 0.03 percentage points. Gri Bio stock is currently +2.75% from its 52-week low of $1.09, and -98.25% from its 52-week high of $64.12.
There are currently 2.19M GRI shares outstanding. The market cap of GRI is $2.45M. In the last 24 hours, 25,000 GRI shares were traded.
You need a brokerage account in order to access the NASDAQ market and buy GRI shares.
Based on our research, eToro is the best stock brokerage. Here's why:
Get $10 towards your share purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've picked the best brokerage, you need to fill out some personal details so you can invest in GRI today.
Now that you have filled out your info on one of the most highly reviewed stock market apps, you can securely and quickly fund your account:
Check out the tutorial below for more details depositing money into your new investment account.
Once you have selected the best place to buy Gri Bio stock, it's critical to analyze their stock before you invest, so you actually wrap your head around the risk and opportunity.
WallStreetZen was built to help everyday investors perform more in-depth fundamental analysis.
You can see all of the due diligence checks on GRI's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge GRI's intrinsic value.
Using relative valuations measures:
You can access more valuation research on GRI's stock here.
Out of 2 sell side analysts who give recommendations on GRI, the consensus analyst rating on GRI is a Buy
Please note that analyst forecasts are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are forecasting on the Gri Bio stock forecast page.
Last year, GRI earnings were -$7.81M. Over the past 2 year, GRI's earnings have gone up by -98.29% per year. This was slower than the Biotechnology industry average of 74.13%.
Learn more about GRI's earnings and revenue performance here.
Over the last year, executives and large shareholders at GRI have not bought or sold any shares.
Research more about who owns GRI stock here.
No, Gri Bio doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
You have two primary options:
Hit the Open Trade button and your broker will place your order.
If you need more assistance buying stocks on eToro, click the how to video below:
Now that you own some GRI shares, you'll want to stay up-to-date on your investment.
Create a watchlist to track the latest developments regarding your GRI stock.
To summarize, here are the 6 steps you need to take to buy Gri Bio stock right now:
If you require a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to keep track of your new investment in Gri Bio, click the button below.